Welcome to BiOasis Corporation

Diagnosis of Alzheimer's Blood Brain Barrier Delivery Platform

The Science of P97 Science Board Members Intellectual Property Validating Studies Publications

Corporate Profile The Market Team Literature and Inquiries News Releases Investors

Studies

biOasis Technologies' acquired a significant Intellectual Property Portfolio from the University of British Columbia. This portfolio has comprehensive coverage in key jurisdictions around the world. The coverage dates back to 1992 and extends forward to 2005-6. The coverage includes patented and proprietary technology in the diagnostic area of Alzheimer's and in the delivery of therapeutics for a variety of neurological diseases.

Further information is available upon request.